Our Pipeline
Prosemble’s drug pipeline is built on the synergy of AI-driven discovery and cutting-edge nanotechnology, aiming to redefine cancer treatment.
Next-Generation Drug Delivery
Harnessing AI and nanotechnology to improve precision, efficacy, and safety in cancer treatment.
Targeted & Responsive Therapies
Our platform ensures controlled drug release, minimising toxicity and maximising therapeutic impact.
Scalable & Cost-Effective Solutions
Innovative nanoparticle technology provides a more accessible alternative to traditional oncology treatments.
Our Pipeline
Doxorubicin
Interferes with the growth and spread of cancer cells. Works on Breast cancer, bladder cancer, Kaposi’s sarcoma, lymphoma, and acute lymphoblastic leukaemia.
Cisplatin
(Causes DNA damage inhibiting replication of cancer cells). Works on Testicular, ovarian, bladder, lung, stomach, and head and neck cancers.
Docetaxel
Inhibits cell division, leading to the death of cancer cells. Works on Breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers.
Cyclophosphamide
Interfering with growth and replication of rapidly dividing cells. Leukaemia, lymphoma, breast cancer, ovarian cancer, and certain types of childhood cancers.
Methotrexate
Inhibiting enzyme dihydrofolate reductase, which is essential for DNA synthesis and cell replication. works on Leukaemia, lymphoma, and certain types of solid tumours.
Vinorelbine
Inhibiting the assembly of microtubules, thus preventing cell division. works on Non-small cell lung cancer and metastatic breast cancer.
siRNA Molecule
Silences gene expression by degrading mRNA molecules with complementary sequences, preventing the production of specific proteins.
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
